Patient and proxy reports regarding the experience of treatment decision-making in cancer care
- PMID: 32840909
- PMCID: PMC7722082
- DOI: 10.1002/pon.5528
Patient and proxy reports regarding the experience of treatment decision-making in cancer care
Abstract
Objective: Shared decision-making, including the elicitation of patient preferences regarding treatment decisions, is considered part of high-quality cancer care. However, patients may not be able to self-report due to illness, and therefore proxy reports may be used. We sought to determine the difference between proxy and patient reports about patient decisions and preferences among patients who received or were scheduled for chemotherapy using data from a large, population-based survey of patients with incident lung or colorectal cancer.
Methods: Of 3573 patients who received or were scheduled for chemotherapy, 3108 self-reported and 465 had proxies reporting on their behalf about preferred and actual decision roles regarding this treatment. Preferred and actual decision roles were assessed using the Control Preferences Scale, and categorized as shared, patient-controlled, or doctor-controlled. Multivariable logistic regression models were used to assess the association between patient and proxy responses and whether preferences were met. The models adjusted for sociodemographic and clinical variables and patient/proxy-reported health status.
Results: Sixty-three percent of all respondents reported actual roles in decisions that matched their preferred roles (role attainment). Proxies and patients were similarly likely to report role attainment (65% vs 63%). In adjusted analyses, proxies were more likely report role attainment (OR = 1.27, 95%CI = 1.02-1.59), but this difference was smaller if health variables were excluded from the model (OR = 1.14, 95%CI = 0.92-1.41).
Conclusion: Most patients' preferences for treatment participation were met. Surveys from proxies appear to yield small differences on the reports of attainment of preferred treatment decision-making roles in cancer care vs surveys from patients.
Keywords: cancer; oncology; patient experience; proxy; psycho-oncology; shared decision-making; treatment preference.
© 2020 John Wiley & Sons Ltd.
Conflict of interest statement
CONFLICT OF INTEREST
Drs Roydhouse, Keating and Wilson have nothing to declare. Dr Gutman reports personal fees from Johnson & Johnson/Janssen, outside the submitted work. Dr Kehl reports paid consulting for Aetion, outside the submitted work.
Similar articles
-
Association of Actual and Preferred Decision Roles With Patient-Reported Quality of Care: Shared Decision Making in Cancer Care.JAMA Oncol. 2015 Apr;1(1):50-8. doi: 10.1001/jamaoncol.2014.112. JAMA Oncol. 2015. PMID: 26182303 Free PMC article.
-
Cancer treatment decision-making among young adults with lung and colorectal cancer: a comparison with adults in middle age.Psychooncology. 2016 Sep;25(9):1085-91. doi: 10.1002/pon.3949. Epub 2015 Sep 2. Psychooncology. 2016. PMID: 26335435 Free PMC article.
-
Preferences and actual chemotherapy decision-making in the greater plains collaborative breast cancer study.Acta Oncol. 2017 Dec;56(12):1690-1697. doi: 10.1080/0284186X.2017.1374555. Epub 2017 Sep 13. Acta Oncol. 2017. PMID: 28903664
-
Development of consensus-based considerations for use of adult proxy reporting: an ISOQOL task force initiative.J Patient Rep Outcomes. 2023 Jun 2;7(1):52. doi: 10.1186/s41687-023-00588-6. J Patient Rep Outcomes. 2023. PMID: 37266745 Free PMC article. Review.
-
A meta-analysis on the role older adults with cancer favour in treatment decision making.J Geriatr Oncol. 2023 Jan;14(1):101383. doi: 10.1016/j.jgo.2022.09.012. Epub 2022 Oct 12. J Geriatr Oncol. 2023. PMID: 36243627 Review.
Cited by
-
Comparing the care experiences of Medicare Advantage beneficiaries with and without Alzheimer's disease and related dementias.J Am Geriatr Soc. 2022 Aug;70(8):2344-2353. doi: 10.1111/jgs.17817. Epub 2022 Apr 29. J Am Geriatr Soc. 2022. PMID: 35484976 Free PMC article.
-
The use of proxies and proxy-reported measures: a report of the international society for quality of life research (ISOQOL) proxy task force.Qual Life Res. 2022 Feb;31(2):317-327. doi: 10.1007/s11136-021-02937-8. Epub 2021 Jul 12. Qual Life Res. 2022. PMID: 34254262 Review.
-
Code status transitions in patients with high-risk acute myeloid leukemia.Blood Adv. 2022 Jul 26;6(14):4208-4215. doi: 10.1182/bloodadvances.2022007009. Blood Adv. 2022. PMID: 35537113 Free PMC article.
References
-
- Institute of Medicine. Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis. Washington, DC: The National Academies Press; 2013. - PubMed
-
- Keating NL, Guadagnoli E, Landrum MB, Borbas C, Weeks JC. Treatment decision making in early-stage breast cancer: should surgeons match patients’ desired level of involvement? J Clin Oncol. 2002;20(6): 1473–1479. - PubMed
-
- Graham C Incidence and impact of proxy response in measuring patient experience: secondary analysis of a large postal survey using propensity score matching. Int J Qual Health Care. 2016;28(2): 246–252. - PubMed
Publication types
MeSH terms
Grants and funding
- U01CA093344/CA/NCI NIH HHS/United States
- U01 CA093348/CA/NCI NIH HHS/United States
- U01 CA093324/CA/NCI NIH HHS/United States
- U01 CA093339/CA/NCI NIH HHS/United States
- U01CA093348/CA/NCI NIH HHS/United States
- U01 CA093326/CA/NCI NIH HHS/United States
- P30AI042853/NH/NIH HHS/United States
- P30 AI042853/AI/NIAID NIH HHS/United States
- CRS02-164/VA/VA/United States
- U01CA093324/CA/NCI NIH HHS/United States
- U01 CA093344/CA/NCI NIH HHS/United States
- U01 CA093332/CA/NCI NIH HHS/United States
- U54GM115677/GM/NIGMS NIH HHS/United States
- U01CA093332/CA/NCI NIH HHS/United States
- U01CA093326/CA/NCI NIH HHS/United States
- U01CA093339/CA/NCI NIH HHS/United States
- K24 CA181510/CA/NCI NIH HHS/United States
- K24CA181510/CA/NCI NIH HHS/United States
- U54 GM115677/GM/NIGMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous